Yamamoto K, Fukui Y, Esaki Y, Inamitsu T, Sudo T, Yamane K, Kamikawaji N, Kimura A, Sasazuki T
Department of Genetics, Kyushu University, Fukuoka, Japan.
J Exp Med. 1994 Jul 1;180(1):165-71. doi: 10.1084/jem.180.1.165.
Studies in vitro have suggested that a species barrier exists in functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecules. However, whether mouse CD4+ T cells restricted by HLA class II molecules are generated in HLA class II transgenic mice and respond to peptide antigens across this barrier has remained unclear. In an analysis of T cell responses to synthetic peptides in mice transgenic for HLA-DR51 and -DQ6, we found that DR51 and DQ6 transgenic mice acquired significant T cell response to influenza hemagglutinin-derived peptide 307-319 (HA 307) and Streptococcus pyogenes M12 protein-derived peptide 347-397 (M6C2), respectively. Inhibition studies with several monoclonal antibodies showed that transgenic HLA class II molecules presented these peptides to mouse CD4+ T cells. Furthermore, T cell lines specific for HA 307 or M6C2 obtained from the transgenic mice could respond to the peptide in the context of relevant HLA class II molecules expressed on mouse L cell transfectants that lack the expression of mouse MHC class II. These findings indicate that interaction between HLA class II and mouse CD4 molecules is sufficient for provoking peptide-specific HLA class II-restricted T cell responses in HLA class II transgenic mice.
体外研究表明,人类组织相容性白细胞抗原(HLA)II类分子与小鼠CD4分子之间的功能相互作用存在物种屏障。然而,受HLA II类分子限制的小鼠CD4+T细胞是否在HLA II类转基因小鼠中产生,并跨越这一屏障对肽抗原作出反应,仍不清楚。在对HLA-DR51和-DQ6转基因小鼠中T细胞对合成肽的反应分析中,我们发现DR51和DQ6转基因小鼠分别对流感血凝素衍生肽307-319(HA 307)和化脓性链球菌M12蛋白衍生肽347-397(M6C2)产生了显著的T细胞反应。用几种单克隆抗体进行的抑制研究表明,转基因HLA II类分子将这些肽呈递给小鼠CD4+T细胞。此外,从转基因小鼠获得的对HA 307或M6C2特异的T细胞系,能够在缺乏小鼠MHC II类表达的小鼠L细胞转染子上表达的相关HLA II类分子的背景下对该肽作出反应。这些发现表明,HLA II类分子与小鼠CD4分子之间的相互作用足以在HLA II类转基因小鼠中引发肽特异性HLA II类限制的T细胞反应。